Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
Asia Pacific Journal of Clinical Nutrition|September 30, 2009
The development of a national salt reduction strategy for AustraliaJacqui Webster, Elizabeth Dunford, Rachel Huxley, et al.
JCO Clinical Cancer Informatics|January 13, 2021
Overall Survival With Second-Line Pembrolizumab in Patients With Non-Small-Cell Lung Cancer: Randomized Phase III Clinical Trial Versus Propensity-Adjusted Real-World DataThomas Jemielita, Xiaoyun Nicole Li, Bilal Piperdi, et al.
ACS Nano|September 11, 2023
Stimuli-Responsive Ion Adsorbents for Sustainable Separation ApplicationsNicole Li, Jue Hou, Ranwen Ou, et al.
Asia Pacific Journal of Clinical Nutrition|December 15, 2010
Consumer awareness and self-reported behaviours related to salt consumption in AustraliaJacqueline L Webster, Nicole Li, Elizabeth K Dunford, et al.
The British Journal of Nutrition|August 20, 2008
The effects of a reduced-sodium, high-potassium salt substitute on food taste and acceptability in rural northern ChinaNicole Li, John Prescott, Yangfeng Wu, et al.
JCO Clinical Cancer Informatics|August 20, 2021
Augmenting Real-World Data Through Modeling Key Clinical Trial Eligibility Criteria: An Example of Patients With Non-small-Cell Lung Cancer Treated With PembrolizumabThomas Jemielita, Xiaoyun Nicole Li, Thomas Burke, et al.
JMIR Mhealth and Uhealth|March 19, 2016
"Smart" RCTs: Development of a Smartphone App for Fully Automated Nutrition-Labeling Intervention TrialsEkaterina Volkova, Nicole Li, Elizabeth Dunford, et al.
American Journal of Nephrology|July 26, 2014
Incidence and relevance of proteinuria in bevacizumab-treated patients: pooled analysis from randomized controlled trialsRichard A Lafayette, Bruce McCall, Nicole Li, et al.
Inflammatory Bowel Diseases|November 15, 2018
The Prevalence and Clinical Associations of Subclinical Sacroiliitis in Inflammatory Bowel DiseaseOrlaith B Kelly, Nicole Li, Michelle Smith, et al.
Cutis|October 27, 2004
Clinical benefits in patients with psoriasis after efalizumab therapy: clinical trials versus practiceRoberto R Ricardo, Matthew Rhoa, Elaine K Orenberg, et al.
Pageof 8